There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Co-Diagnostics (CODX) and Acutus Medical (AFIB) with bullish sentiments.
Co-Diagnostics (CODX)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Co-Diagnostics today and set a price target of $33.00. The company’s shares closed last Friday at $11.42.
According to TipRanks.com, Chen is a 4-star analyst with an average return of 5.0% and a 37.8% success rate. Chen covers the Healthcare sector, focusing on stocks such as Interpace Diagnostics Group, HTG Molecular Diagnostics, and EyePoint Pharmaceuticals.
Co-Diagnostics has an analyst consensus of Moderate Buy, with a price target consensus of $31.50.
See today’s analyst top recommended stocks >>
Acutus Medical (AFIB)
Acutus Medical received a Buy rating and a $40.00 price target from BTIG analyst Marie Thibault today. The company’s shares closed last Friday at $30.96, close to its 52-week high of $31.43.
According to TipRanks.com, Thibault is a 5-star analyst with an average return of 32.5% and a 63.2% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Varian Medical Systems, and Edwards Lifesciences.
Currently, the analyst consensus on Acutus Medical is a Moderate Buy with an average price target of $40.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
